News/ News/ Sales and Marketing/ Top stories Alexion stalks rare disease drug from Stealth with $30m opt-in deal Phil Taylor Alexion, licensing, rare disease, Stealth Therapeutics 0 Comment Alexion has taken an option on a rare disease drug from Stealth Therapeutics in late-stage development, bolstering its Share X Alexion stalks rare disease drug from Stealth with $30m opt-in deal https://pharmaphorum.com/news/alexion-stalks-rare-disease-drug-from-stealth-with-30m-opt-in-deal/
Alexion, licensing, rare disease, Stealth Therapeutics
0 Comment
